Yarrow Bioscience (YARW) Interest Coverage Ratio (QoQ) (2018 - 2024)
Yarrow Bioscience (YARW) Interest Coverage Ratio (QoQ) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 98.45% |
| Sep 30, 2024 | -3,551.78% |
| Jun 30, 2024 | -70.01% |
| Mar 31, 2024 | -175.61% |
| Dec 31, 2023 | 770.97% |
| Sep 30, 2023 | 39.58% |
| Jun 30, 2023 | -75.63% |
| Dec 31, 2021 | 11.50% |
| Sep 30, 2021 | 65.12% |
| Jun 30, 2021 | 3.30% |
| Mar 31, 2021 | -178.51% |
| Dec 31, 2020 | 154.40% |
| Sep 30, 2020 | 86.23% |
| Jun 30, 2020 | -317.93% |
| Mar 31, 2020 | 67.54% |
| Dec 31, 2019 | -1,298.01% |
| Sep 30, 2019 | -144.05% |
| Jun 30, 2019 | -135.96% |
| Mar 31, 2019 | -1.75% |
| Dec 31, 2018 | -52.68% |